Associated Papers
Gene-Environment Interactions in Inflammatory Bowel Disease: A Systematic Review of Human Epidemiologic Studies.
Bai J et al.
Journal of Crohn's & Colitis, 2025
Pharmacogenomic landscape of TNF inhibitors in the Middle Eastern Qatari population.
Jan Z et al.
Frontiers in Immunology, 2025
41346622 (PubMed )
Supplement: Table2.xlsx › Supplementary_Table_8
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › Patient_2_late_met_1
The chronological sequence of somatic mutations in early gastric carcinogenesis inferred from multiregion sequencing of gastric adenomas.
Lim CH et al.
Oncotarget, 2016
27175599 (PubMed )
Supplement: oncotarget-07-39758-s006.xlsx › TableS5
Towards personalized care in IBD.
Gerich ME et al.
Nature Reviews. Gastroenterology & Hepatology, 2014
Clinical and genetic factors predicting response to therapy in patients with Crohn's disease.
Cravo M et al.
United European Gastroenterology Journal, 2014
Thiopurine effectiveness in patients with Crohn's disease: a study of genetic and clinical predictive factors.
Koifman E et al.
Inflammatory Bowel Diseases, 2013
Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity.
Ferreira P et al.
Clinical Nutrition (edinburgh, Scotland), 2010
Select a paper to view details